AcelRx Pharmaceuticals Inc (ACRX)

NASDAQ
1.2000
0.0000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    1.1800/1.1900
  • Day's Range:
    1.1600 - 1.2100

ACRX Overview

Prev. Close
1.2
Day's Range
1.16-1.21
Revenue
5.54M
Open
1.2
52 wk Range
1.02-2.93
EPS
-0.36
Volume
0
Market Cap
142.92M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,174,347
P/E Ratio
-
Beta
0.83
1-Year Change
7.14%
Shares Outstanding
119,102,999
Next Earnings Date
Aug 04, 2021
What is your sentiment on AcelRx Pharmaceuticals Inc?
or
Vote to see community's results!

AcelRx Pharmaceuticals Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell

AcelRx Pharmaceuticals Inc Company Profile

AcelRx Pharmaceuticals Inc Company Profile

Employees
54

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company’s lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. It also develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is based in Hayward, California.

Read More
  • 5$
    0
    • Loading time again
      0
      • loading 4 more 20k
        0
        • 5$
          0
          • many analysts project this to go $5 to $20, but still sinking, if it goes below sma 50 then we'lll be seeing below 1.0 in wks glta :-)
            0
            • Aclrx down down down
              0
              • https://www.genengnews.com/topics/drug-discovery/acelrx-grunenthal-enter-potentially-220m-collab-for-pain-treatment/
                0
                • I hope
                  0
              • https://seekingalpha.com/article/4430374-acelrx-pharmaceuticals-moving-closer-to-an-attractive-risk-reward
                0
                • Bought at 2.23
                  0
                • they lots of phase 3 and ready for commercialisation products so it will only go up and pass that range.....i hope near term but these fake lawsuits is giving negative picture
                  0
                • Just read this one....very interesting.......BIG PHARMA in the Acute Pain sector is VERY VERY WORRIED, rightfully so, I would be too: "The standard of care for perioperative opioid administration has not been disrupted for over 100 years." Yep DSUVIA is a DISRUPTOR, reminds me of the early days of Tesla, Apple, etc. NOBODY like competition after 100 years!
                  0
              • What price u expect
                0
                • https://seekingalpha.com/article/4430374-acelrx-pharmaceuticals-moving-closer-to-an-attractive-risk-reward
                  0
              • This is looking good.......BULLISH?
                0
                • Where acelrx going
                  0
                  • i suspect a BULL is hanging in the air.....this seems to explode very soon
                    0
                  • What price we will see if explode
                    0
                • No news ?the market down acxlrxalso
                  0
                  • How much you think price will be
                    0
                    • i think it will fall not much
                      0
                    • well maybe not much means -20%
                      0
                  • What’s news in company
                    0
                    • good news in 1 week. hold up
                      0
                      • 1.59 i think we need to buy now guys. they have new CEO, she is Ukrainian and very pro, she raised over 30 millions dollars. let's buy and wait for price 2
                        0
                        • Last chance BUY!!!
                          2
                          • Why
                            0
                            • BUY BUY BUY
                              0
                              • out. lose a lot. unpredictable
                                2
                                • https://www.reddit.com/r/pennystocks/comments/lfle4e/acelrx_pharmaceuticals_acrx_just_the_beginning/
                                  0
                                  • $3 today??
                                    0
                                    • buy!
                                      0
                                      • $3 end of this month
                                        0
                                        • up up up
                                          0
                                          • bummed us
                                            0
                                          • ha!
                                            0
                                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.